TY - JOUR JF - ISMJ JO - Iran South Med J VL - 17 IS - 6 PY - 2015 Y1 - 2015/1/01 TI - Study of ethA gene sequence in Ethionamide resistant clinical isolates of Mycobacterium tuberculosis TT - بررسی توالی نوکلئوتیدی ژن ethA در سویه‌های حساس و مقاوم به اتیونامید در باکتری مایکوباکتریوم توبرکلوزیس N2 - Background: Ethionamide (ETH) is a structural analog of isoniazid and secondary line anti-tuberculosis drugs. Both of Ethionamide and isoniazid target INHA protein in mycobacterium tuberculosis. This protein involved in mycolic acid biosynthesis. The purpose of this study is evaluation of sequence of ethA gene in order to detect mutations related to resistance to isoniazide in clinical mycobacterium tuberculosis isolates. Material and Methods: In this study were evaluated 27 resistance and sensitive isolates to ethionamide. Because of length of this fragment (1470bp) were performed three reactions for each sample with ethA-10, ethA-8, ethA-9, ethA-4, ethA-5 and ethA-1 specific primers in PCR reaction. Results: From 27 used clinical isolates, 23 strains were resistant and 4 isolates were susceptible to ETH. Results of electrophoresis were proved proper selection of primers and PCR conditions. DNA sequencing results were determined mutations at some points of the gene in the resistant isolates to ETH, but none of susceptible strains harbored mutations. Conclusion: According to the results it was proved that any mutations in each point of ethA gene could cause resistance to Ethionamid. Rapid molecular detection of the resistance is possible only via complete sequencing of total length of this gene. SP - 1153 EP - 1159 AU - Moazemi, Somaye AU - Arjomandzadegan, Mohammad AU - Ahmadi, Azam AU - Tayebun, Maryam AU - Shojapor, Mana AD - Department of microbiology, Tuberculosis and Pediatric Infectious Disease Research Center , Arak University of Medical Sciences,Arak, IRAN KW - Mycobacterium tuberculosis KW - Drug resistant KW - Ethionamide KW - sequencing UR - http://ismj.bpums.ac.ir/article-1-631-en.html ER -